Skip to main content

Articles on Venous Disease

Case Report
Jailing of the contralateral iliac vein may occur as a result of the iliac vein stent protruding into the IVC. The advent of new, dedicated venous stents with more accurate deployment at the…
Editor's Corner
Craig Walker, MD, comments on the increase in obstructive venous disease procedures, which remain underdiagnosed and undertreated.
Original Research
Golamari and colleagues assessed the applicability of catheter-directed thrombolysis in submassive pulmonary embolism in a community hospital setting. 
IVC Filters
Jafar Golzarian, MD, and Constantino Peña, MD, spoke in a session dedicated to pulmonary embolism (PE) and filters.
Two-year findings from the VIRTUS trial of the VICI venous stent (Boston Scientific) showed a primary patency rate of 79.4%. As has been seen in other trials, primary patency was higher in non-…
ISET Session Coverage
Endovenous stenting to relieve chronic venous disease secondary to post-thrombotic or non-thrombotic iliac vein obstruction is becoming increasingly established.

Hollywood, FL (January 23, 2020) -- Robert Lookstein, MD, presented the 6-month results of the IN.PACT AV access trial at the International Symposium on Endovascular Therapy (ISET).…

Enrollment is completed and baseline demographics available for the ABRE IDE study of the ABRE Venous Stent (Medtronic), according to principal instigator Erin Murphy, MD, director of the venous and…
At two years, primary patency was 84.3% with the Venovo venous stent (BD) in iliac and femoral vein obstructions, with the rates of freedom from target lesion revascularization (TLR) and target…
Interviews
Vascular Disease Management spoke with Raghu Kolluri, MD, MS, RVT, FSVM, President for the Society for Vascular Medicine and System Medical Director, Vascular Medicine at OhioHealth Riverside…
Back to Top